Loading...

Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond One Year after Percutaneous Coronary Intervention: An Analysis from the Randomized Dual Antiplatelet Therapy Study

IMPORTANCE: Dual antiplatelet therapy after percutaneous coronary intervention (PCI) reduces ischemia at the expense of increased bleeding. OBJECTIVE: To develop a clinical decision tool to identify patients expected to derive benefit vs. harm from continuing thienopyridine beyond one year after PCI...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:JAMA
Main Authors: Yeh, Robert W., Secemsky, Eric A., Kereiakes, Dean J., Normand, Sharon-Lise T., Gershlick, Anthony H., Cohen, David J., Spertus, John A., Steg, Philippe Gabriel, Cutlip, Donald E., Rinaldi, Michael J., Camenzind, Edoardo, Wijns, William, Apruzzese, Patricia K., Song, Yang, Massaro, Joseph M., Mauri, Laura
Format: Artigo
Sprog:Inglês
Udgivet: 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5408574/
https://ncbi.nlm.nih.gov/pubmed/27022822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2016.3775
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!